{"id":8215,"date":"2025-04-15T12:11:07","date_gmt":"2025-04-15T04:11:07","guid":{"rendered":"https:\/\/regask.com\/?p=8215"},"modified":"2025-04-15T12:11:07","modified_gmt":"2025-04-15T04:11:07","slug":"regask-aparece-en-un-informe-sobre-atencion-medica-que-trata-los-aranceles-de-china-y-la-atencion-medica-en-ee-uu","status":"publish","type":"post","link":"https:\/\/regask.com\/es\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/","title":{"rendered":"RegASK en Healthcare Brew: C\u00f3mo los aranceles en China..."},"content":{"rendered":"<p class=\"\" data-start=\"238\" data-end=\"530\">Estamos orgullosos de compartir eso <strong data-start=\"264\" data-end=\"306\">El modelo RegASK se ha presentado en <a href=\"https:\/\/www.healthcare-brew.com\/stories\/2025\/02\/25\/how-tariffs-on-china-could-impact-us-healthcare\">Cerveza para el cuidado de la salud<\/a><\/strong>El \u00faltimo art\u00edculo de, <em data-start=\"325\" data-end=\"377\">\u201cC\u00f3mo los aranceles a China podr\u00edan afectar la atenci\u00f3n m\u00e9dica en Estados Unidos\u201d.<\/em> El art\u00edculo explora c\u00f3mo los nuevos aranceles sobre los ingredientes farmac\u00e9uticos chinos podr\u00edan aumentar los precios de los medicamentos, limitar la innovaci\u00f3n y tensionar los sistemas de salud p\u00fablica.<\/p>\n<p class=\"\" data-start=\"532\" data-end=\"924\">Director ejecutivo de RegASK <strong data-start=\"559\" data-end=\"580\">Carolina Shleifer<\/strong> explica los posibles efectos posteriores de estos aranceles, advirtiendo de <strong data-start=\"652\" data-end=\"676\">aumento de los costos de los medicamentos<\/strong>, <strong data-start=\"678\" data-end=\"701\">escasez potencial<\/strong>, y <strong data-start=\"707\" data-end=\"733\">reducci\u00f3n de la inversi\u00f3n en I+D<\/strong>Sus observaciones resaltan la urgencia de que los organismos reguladores, los proveedores de atenci\u00f3n m\u00e9dica y las compa\u00f1\u00edas farmac\u00e9uticas monitoreen los cambios en las pol\u00edticas globales que pueden afectar significativamente el acceso a medicamentos cr\u00edticos.<\/p>\n<p class=\"\" data-start=\"926\" data-end=\"1121\">\ud83d\udd17 Lee el art\u00edculo completo aqu\u00ed: <a class=\"\" href=\"https:\/\/www.healthcare-brew.com\/stories\/2025\/02\/25\/how-tariffs-on-china-could-impact-us-healthcare\" target=\"_new\" rel=\"noopener\" data-start=\"954\" data-end=\"1121\">Healthcare Brew: C\u00f3mo los aranceles a China podr\u00edan afectar la atenci\u00f3n m\u00e9dica en EE. UU.<\/a><\/p>\n<p data-start=\"926\" data-end=\"1121\">Para obtener m\u00e1s informaci\u00f3n sobre c\u00f3mo los cambios de pol\u00edticas, como los aranceles, est\u00e1n transformando la industria farmac\u00e9utica, lea sobre <a href=\"https:\/\/regask.com\/es\/regask-aparece-en-bloomberg-trump-amenaza-con-aranceles-a-la-industria-farmaceutica\/\"><strong data-start=\"1057\" data-end=\"1090\">Art\u00edculo de RegASK en Bloomberg.<\/strong><\/a><\/p>\n<p data-start=\"921\" data-end=\"1114\">En RegASK, estamos comprometidos a brindar inteligencia precisa y procesable para ayudar a los equipos regulatorios a navegar con confianza en el cambiante panorama de cumplimiento actual.<\/p>","protected":false},"excerpt":{"rendered":"<p>Nos enorgullece compartir que RegASK ha aparecido en el \u00faltimo art\u00edculo de Healthcare Brew, &quot;C\u00f3mo los aranceles a China podr\u00edan afectar la atenci\u00f3n m\u00e9dica en EE. UU.&quot; El art\u00edculo explora c\u00f3mo los nuevos aranceles a los ingredientes farmac\u00e9uticos chinos podr\u00edan aumentar los precios de los medicamentos, limitar la innovaci\u00f3n y sobrecargar los sistemas de salud p\u00fablica. La directora ejecutiva de RegASK, Caroline Shleifer, explica los posibles efectos secundarios de estos...<\/p>","protected":false},"author":22,"featured_media":8216,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[528],"tags":[],"class_list":["post-8215","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.3 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>RegASK in Healthcare Brew: Impact of China Tariffs on US Pharma<\/title>\n<meta name=\"description\" content=\"RegASK CEO shares expert insights in Healthcare Brew on how China tariffs could disrupt US healthcare access and innovation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/es\/regask-aparece-en-un-informe-sobre-atencion-medica-que-trata-los-aranceles-de-china-y-la-atencion-medica-en-ee-uu\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RegASK featured in Healthcare Brew: How tariffs on China could impact US healthcare\" \/>\n<meta property=\"og:description\" content=\"RegASK CEO shares expert insights in Healthcare Brew on how China tariffs could disrupt US healthcare access and innovation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/es\/regask-aparece-en-un-informe-sobre-atencion-medica-que-trata-los-aranceles-de-china-y-la-atencion-medica-en-ee-uu\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-15T04:11:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/regask-featured-healthcare-brew.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1201\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Divvya Behal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Divvya Behal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/\"},\"author\":{\"name\":\"Divvya Behal\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/194dd7cb5a4908baaeea7bd8e3dac5d0\"},\"headline\":\"RegASK featured in Healthcare Brew: How tariffs on Chin&hellip;\",\"datePublished\":\"2025-04-15T04:11:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/\"},\"wordCount\":170,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/regask-featured-healthcare-brew.jpg\",\"articleSection\":[\"Company News\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/\",\"name\":\"RegASK in Healthcare Brew: Impact of China Tariffs on US Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/regask-featured-healthcare-brew.jpg\",\"datePublished\":\"2025-04-15T04:11:07+00:00\",\"description\":\"RegASK CEO shares expert insights in Healthcare Brew on how China tariffs could disrupt US healthcare access and innovation.\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/regask-featured-healthcare-brew.jpg\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/regask-featured-healthcare-brew.jpg\",\"width\":1201,\"height\":900,\"caption\":\"Regask Featured Healthcare Brew\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"Empowering Smarter Regulatory Decisions\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/194dd7cb5a4908baaeea7bd8e3dac5d0\",\"name\":\"Divvya Behal\",\"sameAs\":[\"https:\\\/\\\/regask.com\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"RegASK en Healthcare Brew: Impacto de los aranceles chinos en las farmac\u00e9uticas estadounidenses","description":"El director ejecutivo de RegASK comparte conocimientos especializados en Healthcare Brew sobre c\u00f3mo los aranceles de China podr\u00edan afectar el acceso y la innovaci\u00f3n en la atenci\u00f3n m\u00e9dica en EE. UU.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/es\/regask-aparece-en-un-informe-sobre-atencion-medica-que-trata-los-aranceles-de-china-y-la-atencion-medica-en-ee-uu\/","og_locale":"es_ES","og_type":"article","og_title":"RegASK featured in Healthcare Brew: How tariffs on China could impact US healthcare","og_description":"RegASK CEO shares expert insights in Healthcare Brew on how China tariffs could disrupt US healthcare access and innovation.","og_url":"https:\/\/regask.com\/es\/regask-aparece-en-un-informe-sobre-atencion-medica-que-trata-los-aranceles-de-china-y-la-atencion-medica-en-ee-uu\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2025-04-15T04:11:07+00:00","og_image":[{"width":1201,"height":900,"url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/regask-featured-healthcare-brew.jpg","type":"image\/jpeg"}],"author":"Divvya Behal","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Divvya Behal","Est. reading time":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/#article","isPartOf":{"@id":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/"},"author":{"name":"Divvya Behal","@id":"https:\/\/regask.com\/#\/schema\/person\/194dd7cb5a4908baaeea7bd8e3dac5d0"},"headline":"RegASK featured in Healthcare Brew: How tariffs on Chin&hellip;","datePublished":"2025-04-15T04:11:07+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/"},"wordCount":170,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/regask-featured-healthcare-brew.jpg","articleSection":["Company News"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/","url":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/","name":"RegASK en Healthcare Brew: Impacto de los aranceles chinos en las farmac\u00e9uticas estadounidenses","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/regask-featured-healthcare-brew.jpg","datePublished":"2025-04-15T04:11:07+00:00","description":"El director ejecutivo de RegASK comparte conocimientos especializados en Healthcare Brew sobre c\u00f3mo los aranceles de China podr\u00edan afectar el acceso y la innovaci\u00f3n en la atenci\u00f3n m\u00e9dica en EE. UU.","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/regask-featured-healthcare-brew.jpg","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/regask-featured-healthcare-brew.jpg","width":1201,"height":900,"caption":"Regask Featured Healthcare Brew"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Habilitando decisiones regulatorias m\u00e1s inteligentes","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd"]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/194dd7cb5a4908baaeea7bd8e3dac5d0","name":"Divvya Behal","sameAs":["https:\/\/regask.com"]}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/8215","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/users\/22"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/comments?post=8215"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/8215\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media\/8216"}],"wp:attachment":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media?parent=8215"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/categories?post=8215"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/tags?post=8215"}],"curies":[{"name":"Gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}